Tweets: LXRX (Lexicon Pharmaceuticals)

chart
LXRX (Lexicon Pharmaceuticals - Msgs, Twts, Profile)

EnterpriseLeade via Twitter 04:50 PM  04/23/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Given Average Recommendation of “Hold” by Analysts https://t.co/tnsv8p3KHn

WeekHerald via Twitter 04:49 PM  04/23/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Given Average Recommendation of “Hold” by Analysts https://t.co/tdfkJdcB3w

dakotafinancial via Twitter 07:53 AM  04/23/18 reply  |  re-tweet

Analysts Expect Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Will Announce Earnings of -$0.45 Per Share https://t.co/Y69eiHZzls

TheMarketsDaily via Twitter 07:51 AM  04/23/18 reply  |  re-tweet

Zacks: Brokerages Anticipate Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Will Announce Earnings of -$0.45 Per Share https://t.co/0K4Vvppkag

TranscriptDaily via Twitter 07:04 AM  04/23/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) to Release Earnings on Monday https://t.co/BvVGRbehRo

IlliniJJ via Twitter 08:08 PM  04/22/18 reply  |  re-tweet

$LXRX (Msgs, Twts) - top institutional owners: Invus Public Equities Advisors - 55.2% Fidelity Managemen - 15% Ulys LLC - 4.1%

ChartEyez via Twitter 05:03 PM  04/22/18 reply  |  re-tweet

RT @DrSManian: $LXRX (Msgs, Twts) Commercial stage derisked assets in both rare disease and T1DM $SNY (Msgs, Twts) partnership & big milestone payments 2019-2020 PT…

DrSManian via Twitter 12:22 PM  04/22/18 reply  |  re-tweet

$LXRX (Msgs, Twts) Commercial stage derisked assets in both rare disease and T1DM $SNY (Msgs, Twts) partnership & big milestone payments 201… https://t.co/n2cvbR9uEn

AmericanBanking via Twitter 04:26 AM  04/22/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Expected to Announce Quarterly Sales of $20.90 Million https://t.co/IShVwcbqiZ #stocks

OlympiaReport via Twitter 04:25 AM  04/22/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Expected to Announce Quarterly Sales of $20.90 Million https://t.co/Z6O2jIQFlV

TickerReport via Twitter 11:52 AM  04/21/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Receives $25.67 Average Target Price from Analysts https://t.co/fJpCDA9uOs

registrarjourn via Twitter 11:46 AM  04/21/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Receives $25.67 Average Target Price from Analysts https://t.co/lEcXBp9FHy

ledgerzette via Twitter 10:42 AM  04/21/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Earns Daily Media Impact Rating of 0.28 https://t.co/QFb6pdmiVB

dakotafinancial via Twitter 10:40 AM  04/21/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Earns Daily News Sentiment Rating of 0.28 https://t.co/taanTPsIUF

ledgerzette via Twitter 06:14 AM  04/20/18 reply  |  re-tweet

Analysts Expect Lexicon Pharmaceuticals $LXRX (Msgs, Twts) to Post -$0.45 Earnings Per Share https://t.co/YdwpPYYVyi

TickerReport via Twitter 05:58 AM  04/20/18 reply  |  re-tweet

Wedbush Boosts Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Price Target to $40.00 https://t.co/fRljCinYzJ

OlympiaReport via Twitter 05:35 AM  04/20/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Expected to Post Earnings of -$0.45 Per Share https://t.co/o1rcssl2dI

AmericanBanking via Twitter 05:29 AM  04/20/18 reply  |  re-tweet

Analysts Expect Lexicon Pharmaceuticals $LXRX (Msgs, Twts) to Post -$0.45 Earnings Per Share https://t.co/PLrBiOC0Vh #stocks

dispatchtribune via Twitter 05:25 AM  04/20/18 reply  |  re-tweet

Analysts Expect Lexicon Pharmaceuticals $LXRX (Msgs, Twts) to Post -$0.45 Earnings Per Share https://t.co/iIrPFq2Mqo

ConsumerFeed via Twitter 01:58 AM  04/20/18 reply  |  re-tweet

Q1 2018 EPS Estimates for Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Decreased by Analyst https://t.co/PLMTcNCJ6V

AmericanBanking via Twitter 08:32 PM  04/19/18 reply  |  re-tweet

Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Downgraded to “Sell” at Zacks Investment Research https://t.co/CApSAzCBQF #stocks

ChrisValdezz via Twitter 07:27 AM  04/19/18 reply  |  re-tweet

$CPAH (Msgs, Twts) $CEI (Msgs, Twts) $BW (Msgs, Twts) $SCYX (Msgs, Twts) $RGLS (Msgs, Twts) $HTGM (Msgs, Twts) $LXRX (Msgs, Twts) $ICON (Msgs, Twts) Some others I’m currently watching for possible future setups. https://t.co/TF9EQBlebx

ThisLincolnian via Twitter 06:07 AM  04/19/18 reply  |  re-tweet

Brokers Set Expectations for Lexicon Pharmaceuticals’ Q1 2018 Earnings $LXRX (Msgs, Twts) https://t.co/zP4bdq0rsG

dispatchtribune via Twitter 03:33 AM  04/19/18 reply  |  re-tweet

Wedbush Boosts Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Price Target to $40.00 https://t.co/e5pD4hRjjS

dakotafinancial via Twitter 07:54 AM  04/18/18 reply  |  re-tweet

Q1 2018 EPS Estimates for Lexicon Pharmaceuticals $LXRX (Msgs, Twts) Lowered by Wedbush https://t.co/IHrT9esxLh

Top Searches Feeds

StockTalk Aggregated Feed (includes All Daily and Weekly Editions) Add to My Yahoo! Add to Google
Top Searches Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google
Web BuZZ Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google
Twitter BuZZ Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google

Web BuZZ

Yesterday

GE

Today

F
More >> RSS Feed
140 close
You will be redirected to the Twitter's authorization page to approve the BoardCentral to connect to your Twitter account. After your approval, the tweet you have entered will be posted.
Out